{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:12:38Z","timestamp":1760242358906},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.humpath.2007.04.004","type":"journal-article","created":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T12:56:51Z","timestamp":1187701011000},"page":"1760-1763","source":"Crossref","is-referenced-by-count":19,"title":["Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis"],"prefix":"10.1016","volume":"38","author":[{"given":"Sergej","family":"Konoplev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pin-Pen","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Che","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2007.04.004_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00005792-197109000-00001","article-title":"The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome","volume":"50","author":"Ward","year":"1971","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.humpath.2007.04.004_bib2","first-page":"77","article-title":"Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia","volume":"1","author":"Wolf","year":"1987","journal-title":"Hematol Pathol"},{"key":"10.1016\/j.humpath.2007.04.004_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ajcp\/80.2.140","article-title":"Evidence to suggest that the human fetal spleen is not a hematopoietic organ","volume":"80","author":"Wolf","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2007.04.004_bib4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2007.04.004_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2007.04.004_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2007.04.004_bib7","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2007.04.004_bib8","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2006-02-005751","article-title":"Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation","volume":"108","author":"Szpurka","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.04.004_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1309\/JQMR-323G-71Y9-M7MB","article-title":"Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities","volume":"116","author":"Onciu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2007.04.004_bib10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5858\/2006-130-997-DOTJMI","article-title":"Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system","volume":"130","author":"Olsen","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2007.04.004_bib11","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G(T) is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.04.004_bib12","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1182\/blood-2005-09-3900","article-title":"X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET\/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis","volume":"107","author":"Levine","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.04.004_bib13","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/blood-2005-03-1287","article-title":"On the molecular origins of the chronic myeloproliferative disorders: it all makes sense","volume":"105","author":"Kaushansky","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2007.04.004_bib14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.leukres.2006.01.004","article-title":"Mutation screening for JAK2V617F: when to order the test and how to interpret the results","volume":"30","author":"Tefferi","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2007.04.004_bib15","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/modpathol.3800480","article-title":"Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders","volume":"18","author":"O'Malley","year":"2005","journal-title":"Mod Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681770700192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681770700192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T03:16:21Z","timestamp":1629602181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681770700192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S004681770700192X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2007.04.004","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}